Ultragenyx Pharmaceutical Inc.: how funds voted at the meeting of 18 Jun 2024
- Ticker
- RARE
- Meeting
- Season
- year to 30 June 2024
- Filers reporting
- 457
- Ballot items
- 4
457 filers on Form N-PX reported votes at the Ultragenyx Pharmaceutical Inc. meeting of 18 Jun 2024. The records fall into 4 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.
This meeting is in the year to 30 June 2024. The latest season on file is the year to 30 June 2026. The page of Ultragenyx Pharmaceutical Inc. has the latest meeting.
If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.
The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .
The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.
The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.
The page gives records. It gives no investment advice and no advice on how to vote.
Season on this page: year to 30 June 2024. Filings read through . How the figures are made
The ballot
Item 1: Director elections
3 nominees. 85.4% of the reported votes are for. 32 filers withheld from or voted against at least one nominee.
916 vote records from 177 filers. 28 of the 176 filers that marked the item voted against management. 1 filer gave no management mark.
One filer reported a share count too large for the holding. The share split leaves those figures out; the counts of filers keep them. The rule
- Positions of 44 fund families
- For 35
- Abstain or withhold 9
- Against management 9
Item 2: Advisory vote on executive pay (say-on-pay)
642 vote records from 455 filers. 212 of the 440 filers that marked the item voted against management. 15 filers gave no management mark.
2 filers reported share counts too large for the holding. The share split leaves those figures out; the counts of filers keep them. The rule
- Positions of 47 fund families
- For 23
- Against 24
- Against management 23
Item 3: Audit-related items (auditor ratification)
306 vote records from 177 filers. 2 of the 176 filers that marked the item voted against management. 1 filer gave no management mark.
One filer reported a share count too large for the holding. The share split leaves those figures out; the counts of filers keep them. The rule
- Positions of 44 fund families
- For 44
Item 4: COMPENSATION: management items
The company's items in this category are shown together, because filers word and number them differently.
307 vote records from 178 filers. 98 of the 177 filers that marked the item voted against management. 1 filer gave no management mark.
One filer reported a share count too large for the holding. The share split leaves those figures out; the counts of filers keep them. The rule
- Positions of 44 fund families
- For 18
- Against 26
- Against management 25
Positions of the fund families
A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.
KeyForAgainstAbstain or withholdSplit or no voteAgainst management
| Fund family | 2. Say-on-pay | 3. Auditor |
|---|---|---|
| AllianceBernstein | Against, against management | For |
| Allspring | Against, against management | For |
| American Century | Against, against management | For |
| BlackRock and iShares | For | For |
| BNY Mellon | Against, against management | For |
| Brighthouse Funds | For | For |
| Charles Schwab | For | For |
| Columbia Threadneedle | Against, against management | For |
| Dimensional | Against, against management | For |
| DWS | Against, against management | For |
| Equitable | Against, against management | For |
| Federated Hermes | For | For |
| Fidelity | For | For |
| First Trust | Against, against management | For |
| Franklin Templeton | Against, against management | For |
| Global X | For | For |
| Goldman Sachs | Against, against management | For |
| Guggenheim and Rydex | Against, against management | For |
| Hartford Funds | For | For |
| Invesco | For | For |
| J.P. Morgan | For | For |
| Jackson National funds | For | For |
| Janus Henderson | Against, against management | No report |
| John Hancock and Manulife | Against, against management | For |
| Lincoln Financial | Against | For |
| Macquarie and Delaware Funds | Against, against management | For |
| MassMutual | For | For |
| MFS | Against, against management | For |
| Morgan Stanley, Eaton Vance and Calvert | Against, against management | For |
| Nationwide | Against, against management | For |
| Natixis and Loomis Sayles | For | No report |
| Neuberger Berman | For | No report |
| Northern Trust and FlexShares | For | For |
| Nuveen and TIAA | Against, against management | For |
| Pacific Life funds | Against, against management | For |
| PGIM and Prudential | For | For |
| Principal | For | For |
| ProShares and ProFunds | Against, against management | For |
| Russell Investments | For | For |
| SEI | For | For |
| State Street and SPDR | For | For |
| T. Rowe Price | For | For |
| Transamerica | For | For |
| Vanguard | For | For |
| Victory Capital | Against, against management | For |
| Virtus | Against, against management | For |
| Voya | For | For |
Questions
- How many filers reported votes at the Ultragenyx Pharmaceutical Inc. meeting?
- 457 Form N-PX filers reported votes at the meeting of 18 Jun 2024. On say-on-pay, 212 of 440 filers that marked the item voted against management (48.2%).
- Is this the result of the meeting?
- No. The page counts the filers that report on Form N-PX, and the shares they reported. Ultragenyx Pharmaceutical Inc. reports the result of a vote on Form 8-K.
- Why does the page show counts only for director elections?
- A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Ultragenyx Pharmaceutical Inc. with a meeting date within three days of 18 Jun 2024. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .